Stay updated with breaking news from Akili Interactive. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jon David brings deep expertise in building and launching engaging products to the Akili leadership team ... | March 17, 2022
A prescription, digital therapeutic shows measureable brain changes that correlate with improved attention control in children with attention deficit hyperactivity disorder.
The financing round was led by Concord Health Partners, with AlbaCore Capital Group and Hambro Perks also contributing. The latest haul follows a $125 million raise that the company announced in October.
Investegate announcements from PureTech Health PLC, PRTC's Akili Files Registration Statement on S-4